Buy Ciplar LA (Propranolol Hydrochloride) Online — Cipla Non-Selective Beta-Blocker for Hypertension, Angina, Migraine Prophylaxis & Essential Tremor

🕓 Propranolol — Six Decades of Clinical Practice

🎯 Where Propranolol Is Chosen Across Specialties

⚖️ PROPRANOLOL — FIVE PRACTICAL CONCERNS

Each concern is covered in detail in sections 11-13, 27, and 10.

🧭 Reader Navigation — Jump to What Matters for You

• First prescription and titration: sections 8, 9
• Propranolol vs atenolol comparison: section 4
• Migraine prevention: section 6
• Essential tremor and performance anxiety: section 7
• Thyrotoxicosis symptom control: section 19
• Portal hypertension in cirrhosis: section 21
• CNS side effects (nightmares, mood): section 11
• The mandatory taper rule: section 27

💊 Propranolol Pharmacokinetics at a Glance

🧪 Three Pharmacological Consequences

Why Ciplar-LA Solves the Half-Life Problem

Standard immediate-release propranolol's 3-6 hour half-life requires TID or QID dosing for stable effect. Ciplar-LA uses controlled-release capsule technology to deliver drug over 12-24 hours, allowing genuine once-daily dosing. The onset of effect is slower (6 hours vs 1-2), so LA is not the formulation for acute settings.

🧬 Beta-1 vs Beta-2 Receptor Effects and Blockade Consequences

Consequences of Non-Selective Blockade — The Double-Edged Sword

Why Non-Selectivity Both Widens and Narrows the Indications

Propranolol's non-selectivity gives it therapeutic uses that cardioselective agents cannot match (essential tremor, migraine, portal hypertension, thyrotoxicosis). But the same non-selectivity is why propranolol is not the first choice for uncomplicated hypertension in patients with asthma, COPD, diabetes with hypoglycaemia risk, or peripheral vascular disease. Cardioselective agents (atenolol, bisoprolol, metoprolol) are preferred in those settings.

🔬 Propranolol vs Atenolol Side by Side

Propranolol Position in Modern Hypertension Guidelines

Beta blockers as a class were demoted from first-line hypertension therapy in the mid-2000s following the ASCOT-BPLA finding that atenolol produced worse cardiovascular outcomes than newer classes at equivalent BP reduction. Propranolol is not disqualified from HTN use but is not first-line for uncomplicated hypertension. It earns its BP-lowering role when hypertension coexists with migraine, tremor, thyrotoxicosis, portal hypertension, or angina — one drug for two problems.

🧠 Propranolol for Migraine Prevention at a Glance

When Propranolol Migraine Prophylaxis Is Considered

• Episodic migraine 4+ days/month with significant disability
• Migraine plus hypertension or angina — single drug covers both
• Migraine unresponsive to abortive therapy alone (triptans, NSAIDs)
• Migraine plus essential tremor — dual benefit
• Migraine plus performance anxiety — multi-purpose

Dr Diarra-Kone on propranolol migraine prophylaxis

"In our neurology practice in Ouagadougou, propranolol remains one of the most useful migraine preventives available — particularly in resource settings where newer options (CGRP monoclonal antibodies) are not accessible or affordable. The critical counselling points are that full effect takes 2-3 months to develop, that the daily dose needs consistent adherence, and that patients should not discontinue abruptly if they decide the drug is not working. Propranolol is well-tolerated in most patients and produces meaningful reduction in migraine frequency in about half of users who take it appropriately."

Fatoumata B. Diarra-Kone, MD, DES — Department of Neurology, Universite Joseph Ki-Zerbo, Centre Hospitalier Universitaire Yalgado Ouedraogo

✋ Essential Tremor — First-Line Pharmacotherapy

🎭 Performance Anxiety — Somatic Symptom Control

Musicians, public speakers, actors, and athletes have used propranolol for decades to control the peripheral somatic symptoms of performance anxiety — tremor, palpitations, sweating, tachycardia — without producing the cognitive dulling of benzodiazepines.

• Dose: 10-40 mg IR taken 1-2 hours before performance
• Formulation: IR only — LA is not the right formulation for occasional PRN use
• Effect: reduces tachycardia and tremor; does not reduce cognitive anxiety or improve confidence
• Trial before performance: never take propranolol for the first time immediately before an important event

Dr O'Suilleabhain-Buckley on performance anxiety use in clinical practice

"Propranolol for performance anxiety is a genuinely useful tool when properly framed. It does not treat anxiety in the cognitive sense — it treats the somatic manifestations. A musician with fine tremor that ruins concert performance, or a public speaker whose voice trembles from tachycardia, benefits substantially. But the patient must understand that they will still feel anxious cognitively, and they must trial the drug at least once before a high-stakes performance to know their individual response. In Irish clinical practice we frame this use case carefully and ensure the patient is not using propranolol as an alternative to addressing underlying anxiety disorder."

Ashling M. O'Suilleabhain-Buckley, MB BCh BAO, FCAI — Department of Anaesthesiology, St. James's Hospital Dublin

📆 Propranolol Formulations Compared

Titration for Chronic Hypertension on Ciplar-LA

1. Start: 80 mg Ciplar-LA once daily in the morning
2. Review at 2-4 weeks: home BP; resting HR; symptomatic tolerance (fatigue, mood, sleep)
3. Titrate up if needed: to 120 mg, then 160 mg once daily
4. Maximum: 240 mg per day (may need to split as 160 mg + 80 mg BID)
5. Combine if not at target: thiazide, ACE-I/ARB, or dihydropyridine CCB

🚩 DO NOT OPEN, CRUSH, OR CHEW CIPLAR-LA CAPSULES

The long-acting matrix relies on intact capsule structure. Crushing releases the full daily dose over 1-2 hours, producing severe bradycardia, hypotension, and bronchospasm. If swallowing difficulty prevents capsule use, IR tablets three or four times daily are the alternative.

🚩 PATIENTS WHO NEED SPECIALIST INPUT BEFORE STARTING

• Resting heart rate below 55 bpm at baseline
• Any AV block beyond first-degree on baseline ECG
• Heart failure with reduced ejection fraction without cardiology supervision
• Asthma, severe COPD, or reactive airway disease — propranolol strongly contraindicated
• Significant peripheral vascular disease (Raynaud, claudication)
• Insulin-treated diabetes with hypoglycaemia unawareness
• Prinzmetal variant angina — contraindicated
• Untreated phaeochromocytoma (need alpha blockade first)

▶️ Practical Initiation Measures

Counselling at First Prescription

Every patient starting propranolol must be told at the first visit that: they should never stop the drug suddenly (rebound syndrome); they should report any new nightmares, mood changes, or excessive fatigue; they should watch for wheezing or shortness of breath; if diabetic on insulin, they should monitor glucose more carefully because of hypoglycaemia masking. This conversation earns its place at the moment the drug is prescribed, not weeks later.

The Smoking-Propranolol Interaction

Cigarette smoking induces CYP1A2, reducing propranolol levels by 30-50%. This has two practical consequences: smokers may need higher doses to achieve BP or HR control; and a patient who quits smoking on stable propranolol may experience increased drug effect (bradycardia, hypotension) as CYP1A2 activity normalises over 4-6 weeks. Dose adjustment during smoking cessation is often needed.

😴 CNS Side Effects on Propranolol

Practical Management of CNS Effects

1. Wait 2-4 weeks — some CNS effects improve as tolerance develops
2. Dose reduction if effects persist and BP allows
3. Timing change — taking LA at bedtime may reduce daytime sedation but worsen nightmares; individualised
4. Switch to atenolol or bisoprolol (hydrophilic, less CNS penetration) if effects persist and cardiovascular indication remains
5. Never abrupt stop — even for intolerable side effects, taper (section 27) applies

The Depression Question

Whether propranolol truly causes clinical depression remains debated. Large observational studies have not consistently shown increased depression incidence, but individual patients do report mood decline that resolves on drug discontinuation. If depression emerges on propranolol, switch to a cardioselective agent (atenolol, bisoprolol) is preferred over antidepressant addition on top of propranolol, particularly in patients with prior depression history.

🚩 PROPRANOLOL AND AIRWAY DISEASE — THE HARD RULES

• Asthma at any severity: propranolol is CONTRAINDICATED
• History of severe asthma or near-fatal asthma: CONTRAINDICATED
• Severe COPD with bronchial reactivity: avoided
• Even mild reactive airway disease: cardioselective beta blocker (atenolol, bisoprolol) at low dose is the alternative

The lower-severity end of the spectrum is where cardioselective agents can be used cautiously. Propranolol is not the choice for any patient with clinically meaningful reactive airway disease.

The Beta Agonist Bronchodilator Conflict

Propranolol blocks the very receptor that bronchodilator drugs (salbutamol, salmeterol, formoterol) target. This means:

• Bronchodilator effect is reduced in patients on propranolol
• Acute asthma attack rescue is compromised
• Emergency management of bronchospasm on propranolol may require higher bronchodilator doses, systemic steroids, or IV epinephrine

If Bronchospasm Occurs on Propranolol

Emergency response: high-dose inhaled salbutamol (may need higher than usual doses); IV steroids; nebulised ipratropium; consider IV magnesium; in severe cases, IV epinephrine. Propranolol should be stopped — but never abruptly in a chronic user. In the acute setting, the wheeze is treated first; the taper begins once the patient is stabilised.

🍬 How Propranolol Blunts Hypoglycaemia Recognition

When blood glucose falls, the body normally releases counter-regulatory hormones that produce adrenergic warning symptoms — tachycardia, tremor, palpitations, anxiety, sweating. These are the "shakiness" that alerts the diabetic patient to check their glucose.

Beta blockade removes several of these warning symptoms: beta-1 blockade removes tachycardia and palpitations; beta-2 blockade removes fine tremor. Sweating persists (mediated by acetylcholine) so it becomes the main remaining warning — but many diabetic patients rely on tremor and tachycardia as their first alert.

Why Non-Selective Propranolol Is Worse Than Cardioselective Atenolol Here

• Beta-2 blockade impairs hepatic glucose recovery from hypoglycaemia (blocks glycogenolysis)
• Beta-2 blockade removes fine tremor — another warning symptom lost
• Blunted glucose-recovery response can prolong hypoglycaemic episodes

Practical Measures for the Diabetic Propranolol User

1. Prefer cardioselective agents (atenolol, bisoprolol) in insulin-treated diabetes if a beta blocker is needed and propranolol is not specifically indicated
2. If propranolol is unavoidable (migraine, tremor, portal HTN in cirrhosis with diabetes), intensify glucose monitoring
3. Educate about sweating as preserved warning — unexplained sweating in a diabetic on propranolol is a specific signal to check glucose
4. Adjust glucose targets modestly higher during initiation to reduce hypoglycaemia risk
5. CGM if available — captures asymptomatic and nocturnal lows
6. Household education about recognising subtle hypoglycaemia signs

💓 A Practical Home Monitoring Routine

1. Resting heart rate: seated 5 minutes; pulse function on BP cuff or radial pulse 30 sec x 2
2. Blood pressure: standard technique — seated, feet flat, back supported, cuff at heart level
3. Twice daily: morning before medication (trough) and evening (approximate peak for LA)
4. Weekly log before office review; discard first day; average the rest
5. In migraine users: additionally note migraine days for effect tracking
6. In tremor users: note tremor severity 0-10 scale

Target Ranges by Indication

Bradycardia Thresholds — When to Act

Resting HR 55-70 bpm is typically therapeutic. HR 45-55 asymptomatic is generally acceptable. Below 45 with symptoms or below 40 asymptomatic warrants prescriber contact and possible dose reduction. Symptomatic bradycardia at any rate needs review.

✅ Renal Impairment — Minimal Impact

Propranolol does not require dose adjustment for renal impairment across the CKD spectrum — this is a genuine advantage over renally-cleared beta blockers (atenolol, nadolol) in patients with declining kidney function. Propranolol is not significantly dialysable, so no post-dialysis supplementation is needed.

Hepatic Impairment Dose Adjustment

The Cirrhosis Special Case

Cirrhosis with portal hypertension is exactly the specific indication where propranolol is used despite the hepatic impairment. In this setting the drug is titrated to specific HR endpoints rather than fixed dose, with careful attention to symptomatic tolerance. Section 21 covers this in detail.

🚨 SEEK URGENT MEDICAL CARE FOR

• Wheezing, shortness of breath, or acute asthma-like symptoms
• Chest pain that is new or worse in an angina patient
• Syncope or near-syncope not clearly postural
• Resting heart rate below 40 bpm with symptoms
• Signs of severe hypoglycaemia in diabetic patient (confusion, seizure, coma)
• Suicidal thoughts or severe mood decline
• New or worsening shortness of breath — possible decompensating HF

⚠️ Contact Prescriber Same or Next Day For

• Persistent vivid nightmares affecting sleep
• New or worsening low mood
• Home resting HR persistently below 45 bpm
• Home BP persistently below 100/60 mmHg
• Progressive exercise intolerance or fatigue
• Cold hands and feet worsening or Raynaud symptoms new
• New medication started elsewhere — interaction check
• Upcoming surgery — discuss perioperative management

Never Stop Abruptly Even for Warning Signs

The response to a warning sign is contact prescriber, not self-directed cessation. Abrupt withdrawal produces the rebound syndrome (section 27) which can be more dangerous than the original side effect. The prescriber will arrange a supervised taper or alternative management.

🩹 Common Propranolol Side Effects with Expected Trajectory

Where Propranolol's Profile Is Favourable

Genuine multi-indication drug (one prescription covers multiple problems); no renal dose adjustment (advantage in CKD); no electrolyte disturbance; effective for essential tremor and migraine that cardioselective agents do not treat well. These are the settings where propranolol's side effect burden is worth the trade-off.

❤️ Propranolol Post-MI

Propranolol for Chronic Stable Angina

The anti-anginal effect works through direct reduction in myocardial oxygen demand:

• Slower resting HR extends diastolic filling time and coronary perfusion
• Reduced contractility lowers oxygen consumption per beat
• Reduced exercise HR increases exertion threshold before angina develops
• Target resting HR: 55-65 bpm; exertional HR under 100 at reasonable exertion

Dr Novotny-Prochazka on propranolol's modern cardiology position

"Propranolol was one of the drugs that established the beta blocker class in post-MI care in the 1980s, and its BHAT-supported mortality benefit remains the historical foundation. In current Czech cardiology practice we typically prefer cardioselective beta blockers (bisoprolol especially) as first-line post-MI because of the wider heart-failure evidence, but propranolol retains a genuine role in specific patients — those with concurrent migraine, essential tremor, or thyrotoxicosis where the drug does multiple jobs. What we do not use propranolol for is asthmatic post-MI patients; cardioselective agents at low dose are the alternative in that specific population."

Jaroslav K. Novotny-Prochazka, MD, PhD — Department of Cardiovascular Medicine, Charles University Prague First Faculty of Medicine

🌤️ Propranolol's Dual Role in Thyrotoxicosis

Dosing for Symptomatic Thyrotoxicosis

• Starting dose: 40 mg IR TID or 80 mg Ciplar-LA once daily
• Titration: to control resting HR and tremor; typically 80-160 mg/day total
• Duration: until definitive treatment (antithyroid drugs, radioiodine, thyroidectomy) achieves euthyroidism
• Tapering off: as symptoms resolve and thyroid function normalises

Thyroid Storm — The Emergency Setting

Thyroid storm is a life-threatening decompensation. IV propranolol (or oral high-dose) is a critical component of management alongside antithyroid drugs, corticosteroids, and supportive care. Propranolol's T4-to-T3 blockade contributes specifically here beyond simple heart rate control. This is a hospital ICU-level emergency, not outpatient management.

⏰ Missed Dose on Ciplar-LA (Once Daily)

Missed Dose on IR Propranolol (TID or QID)

❌ Doubling Up Is Never Useful

A doubled dose of propranolol produces symptomatic bradycardia and hypotension that can last many hours (particularly on LA). Skip and resume schedule instead. The rebound risk from a missed dose is much smaller than the toxicity risk from a doubled dose.

🩹 How Propranolol Reduces Portal Pressure

Two complementary effects reduce portal venous pressure:

• Beta-1 blockade: reduced cardiac output means less blood volume delivered to the splanchnic circulation
• Beta-2 blockade: unopposed alpha-1 vasoconstriction in splanchnic vessels reduces portal inflow further

The net effect is 15-25% reduction in portal pressure in responders — enough to substantially reduce variceal bleeding risk.

Portal Hypertension Indications

Propranolol Titration in Portal Hypertension

1. Start: 40 mg BID (IR) or 80 mg Ciplar-LA once daily
2. Titrate every 1-2 weeks against home HR
3. Target: 25% reduction in resting HR from baseline OR resting HR 55-60 bpm (whichever comes first) OR symptomatic limit
4. Typical maintenance dose: 80-240 mg/day; sometimes higher
5. Ongoing surveillance: home HR, BP, ascites status, cognitive function

Dr Vanmeenen-Rouseeuw on propranolol in cirrhotic portal hypertension

"In the hepatology clinic at Ghent University Hospital, non-selective beta blockers remain a cornerstone of variceal bleeding prevention. Propranolol is the most extensively studied of these agents, and its role is specifically as a non-selective beta blocker — the splanchnic vasoconstriction from beta-2 blockade is what makes it work at the portal circulation. What we watch for carefully is decompensation with refractory ascites, where propranolol may worsen renal perfusion, and severe hyponatraemia where the balance shifts against beta blockade. The dose is not fixed but titrated to physiological endpoints (heart rate, or invasively-measured hepatic venous pressure gradient when available)."

Nikolaas H. Vanmeenen-Rouseeuw, MD, PhD — Cirrhosis and Portal Hypertension Unit, Ghent University Hospital

🕰️ Elderly-Specific Propranolol Considerations

Beers Criteria Note

The American Geriatrics Society Beers Criteria do not blacklist propranolol but note the higher CNS side effect burden compared to cardioselective agents. Where the indication does not specifically require non-selectivity (essential tremor, migraine, portal HTN), cardioselective alternatives are often preferred in the elderly.

A Beta Blocker Choice Question in CKD

A patient with declining kidney function who needs a beta blocker (post-MI, hypertension, angina) may benefit from switching from atenolol (renally cleared, needs dose adjustment) to propranolol or metoprolol (hepatically cleared, no adjustment needed). This decision depends on the specific indication and comorbidities; specialist input helpful.

💥 PROPRANOLOL + VERAPAMIL/DILTIAZEM

Both drugs act at the AV node and reduce contractility. Combined, they can produce:

• Severe bradycardia and heart block
• Acute heart failure in borderline LV function
• Symptomatic hypotension and syncope

The combination is generally avoided. When both drugs seem needed, specialist supervision is essential.

Other AV-Slowing Combinations to Watch

• Digoxin plus propranolol: additive AV block; useful in AF rate control but requires ECG monitoring
• Amiodarone plus propranolol: additive bradycardia; specialist decision
• Ivabradine plus propranolol: specific ivabradine mechanism plus beta blocker HR effect — combination sometimes used in HF but requires close monitoring
• Topical timolol eye drops: systemically absorbed; can add to bradycardia in propranolol user

If Propranolol + Rate-Slowing CCB Is Started

Baseline ECG documenting sinus rhythm and PR interval; baseline echocardiogram confirming LV function above 40%; both drugs at lowest effective doses; ECG at 1 and 4 weeks; home HR monitoring twice daily; specialist involvement.

🚫 ABSOLUTE CONTRAINDICATIONS

• Asthma at any severity
• Severe COPD with reactive airway component
• Second-degree Mobitz Type II or third-degree AV block without pacemaker
• Sick sinus syndrome without pacemaker
• Symptomatic bradycardia below 45 bpm
• Cardiogenic shock or acute decompensated heart failure
• Prinzmetal (variant) angina — beta blockade can worsen vasospasm
• Untreated phaeochromocytoma — alpha blockade must be established first
• Documented propranolol hypersensitivity

⚠️ RELATIVE CONTRAINDICATIONS AND SPECIFIC CAUTIONS

• Insulin-treated diabetes with hypoglycaemia unawareness — cardioselective alternative preferred
• Peripheral vascular disease (Raynaud, severe claudication)
• Severe hepatic impairment — unless propranolol is specifically indicated
• Depression or psychiatric history — enhanced CNS burden
• Concurrent verapamil or diltiazem — combination generally avoided (section 24)
• Concurrent clonidine — discontinuation trap
• First-degree AV block with PR above 240 ms — caution
• Pregnancy — not first-line; specialist decision
• Age under 18 — specialist decision (except infant hemangioma with Hemangeol)

Approximate Beta Blocker Dose Equivalences

Propranolol 80 mg (Ciplar-LA once daily) is approximately equivalent to atenolol 50 mg, metoprolol tartrate 50 mg BID, bisoprolol 5 mg, or carvedilol 12.5 mg BID for BP effect. Higher doses scale roughly proportionally. These are practical approximations; individual titration guided by home HR and BP over 2-4 weeks is required after any switch.

⛔ NEVER STOP CIPLAR-LA ABRUPTLY

Chronic propranolol use upregulates beta receptors. Sudden cessation unmasks this receptor sensitisation, producing amplified adrenergic response for 5-14 days.

Clinical consequences: rebound tachycardia; rebound hypertension; angina resurgence; rarely myocardial infarction; arrhythmias; tremor and anxiety symptoms.

Practical Taper Schedule for Elective Withdrawal

If Also on Clonidine — The Discontinuation Order Matters

A patient on both propranolol and clonidine who is discontinuing either drug must taper the beta blocker FIRST, then wait 3-7 days before starting clonidine taper. Stopping clonidine while propranolol is still active produces unopposed alpha-1 vasoconstriction and severe rebound hypertensive crisis.

🌡️ Storage and Handling

• Room temperature 20-25 °C
• Dry environment — humidity affects tablets and capsule integrity
• Original packaging for moisture protection
• Out of direct sunlight
• Out of reach of children — propranolol overdose in children can cause profound bradycardia, hypotension, hypoglycaemia
• Check expiry date before use

🚩 NEVER CRUSH, CHEW, OR OPEN CIPLAR-LA CAPSULES

The controlled-release matrix must remain intact for the 24-hour release mechanism to work. Crushing destroys the mechanism, delivering the full daily dose over 1-2 hours — producing severe bradycardia, hypotension, and (in reactive airway users) bronchospasm.

If swallowing difficulty prevents capsule use, alternatives include IR tablets three or four times daily, or in specific cases opening the capsule for sprinkling on soft food per manufacturer instructions (only where the manufacturer specifically states this is permitted).

✈️ Travel Preparation Checklist

1. Carry trip supply plus 7-10 extra days — buffer against delays and lost luggage
2. Split supply between carry-on and checked luggage; carry-on portion is essential
3. Keep capsules in original packaging for customs
4. Carry the prescription label for international travel
5. Note the generic name (propranolol hydrochloride) for local pharmacy identification
6. Time zones: shift daily dose timing by 1-2 hours per day of travel; single missed dose is tolerable, do not double up

Running Out on Travel — A Specific Hazard

Running out of propranolol in a foreign country over a weekend can precipitate the rebound withdrawal syndrome within 24-48 hours. Emergency pharmacy supply arrangements exist in most jurisdictions — use them rather than skip doses. Wearable medical ID mentioning propranolol use helps in any medical emergency abroad.

Long-Haul Flights and Propranolol

Long flights combine dehydration, immobility, and cabin hypoxia. On propranolol, staying hydrated, walking regularly, and avoiding excess alcohol reduce the small increased DVT risk on antihypertensive therapy. Cold extremities may be more prominent during flights — warm socks and gloves help.

💬 A Useful Annual-Review Conversation on Ciplar-LA

1. Home BP and HR readings for the past week: averages, at target?
2. Adherence check: missed doses in past month?
3. CNS side effects: nightmares, sleep, mood, cognitive function
4. Indication review: is propranolol still the right beta blocker for the current situation?
5. Airway symptoms: any wheeze or new dyspnoea?
6. Cold extremities, sexual function, weight change
7. Blood work: creatinine, LFT if indicated; glucose in diabetics
8. Interacting medications: new drugs from other prescribers?
9. Life changes: planned pregnancy, new asthma, new depression, recurrent falls
10. Never-abrupt-stop reminder: reinforce every year

❓ Three Questions Worth Asking Your Prescriber

1. Is propranolol still the right beta blocker for me? If the specific reason for non-selectivity is gone, cardioselective alternatives may be cleaner.
2. Am I on the right dose? Home HR data guides the answer.
3. What is the plan if I need to stop? Understanding the taper protects against emergency situations.

A Closing Note

"Propranolol is one of the most remarkable drugs in modern medicine. Sir James Black's original insight in the 1960s that a selectively targeted receptor antagonist could be therapeutically useful opened an entire era of rational drug design and earned him the Nobel Prize a quarter-century later. Six decades on, propranolol continues to serve a genuinely wide clinical role across cardiology, neurology, endocrinology, hepatology, and even paediatric dermatology (infantile hemangioma) — more indications than almost any other drug in the modern formulary. When patients understand the specific rules (never abrupt, watch for CNS effects, know the airway contraindication, take the LA capsule whole), Ciplar-LA is a reliable partner in cardiovascular and non-cardiovascular care for years to come."

Sirikorn P. Rattanaphon-Wongsawat, MD, MPH — Department of Family Medicine and Community Health, Chulalongkorn University Faculty of Medicine